Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1150 ARTÍCULOS , VIENDO DEL 886 AL 900

Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease

Visser PJ, Vos S, van Rossum I, Scheltens P.

Alzheimers Dement. 2012 Nov;8(6):560-3. doi: 10.1016/j.jalz.2011.10.008.

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician

Budson AE, Solomon PR.

Neurologist. 2012 Nov;18(6):356-63. doi: 10.1097/NRL.0b013e31826a998d.

Clinical diagnosis in preclinical stage of Alzheimer's disease

Fuentes P.

Arch Med Res. 2012 Nov;43(8):667-70. doi: 10.1016/j.arcmed.2012.10.014. Epub 2012 Nov 3.

Emerging noninvasive biomarkers for early detection of Alzheimer's disease

Guzmán-Martínez L, Farías GA, Maccioni RB.

Arch Med Res. 2012 Nov;43(8):663-6. doi: 10.1016/j.arcmed.2012.10.013. Epub 2012 Nov 7.

Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia

Román G, Pascual B.

Arch Med Res. 2012 Nov;43(8):671-6. doi: 10.1016/j.arcmed.2012.10.018. Epub 2012 Nov 8.

Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?

Bhamra MS, Ashton NJ.

Electrophoresis. 2012 Dec;33(24):3598-607. doi: 10.1002/elps.201200161. Epub 2012 Nov 26.

[Calcium hypothesis of Alzheimer disease]

Riazantseva MA, Mozhaeva GN, Kaznacheeva EV.

Usp Fiziol Nauk. 2012 Oct-Dec;43(4):59-72.

mCiRNA-synaptic crystal ball?

Bredesen D.

Aging (Albany NY). 2012 Nov;4(11):732-3. doi: 10.18632/aging.100511.

[Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]

Lanfranco RG, Manríquez-Navarro P, Avello LG, Canales-Johnson A.

Rev Med Chil. 2012 Sep;140(9):1191-200. doi: 10.4067/S0034-98872012000900014.

[Exploring the early diagnostic biomarkers for Alzheimer's disease]

Yamasaki T, Tobimatsu S.

Fukuoka Igaku Zasshi. 2012 Nov;103(11):215-25.

Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology

Beeri MS, Schmeidler J, Lesser GT, Maroukian M, West R, Leung S, Wysocki M, Perl DP, Purohit DP, Haroutunian V.

Neurobiol Aging. 2012 Jul;33(7):1258-64. doi: 10.1016/j.neurobiolaging.2011.02.011. Epub 2011 Apr 1.

The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization

Kaden D, Munter LM, Reif B, Multhaup G.

Eur J Cell Biol. 2012 Apr;91(4):234-9. doi: 10.1016/j.ejcb.2011.01.017. Epub 2011 Apr 2.

Glutamate receptors in preclinical research on Alzheimer's disease: update on recent advances

Hu NW, Ondrejcak T, Rowan MJ.

Pharmacol Biochem Behav. 2012 Feb;100(4):855-62. doi: 10.1016/j.pbb.2011.04.013. Epub 2011 Apr 22.

Attention-related networks in Alzheimer's disease: a resting functional MRI study

Li R, Wu X, Fleisher AS, Reiman EM, Chen K, Yao L.

Hum Brain Mapp. 2012 May;33(5):1076-88. doi: 10.1002/hbm.21269. Epub 2011 Apr 29.

Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial

Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG; ADAPT Research Team.

Int J Geriatr Psychiatry. 2012 Apr;27(4):364-74. doi: 10.1002/gps.2723. Epub 2011 May 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias